215 related articles for article (PubMed ID: 27904030)
1. Formulation Optimization and in Vitro Characterization of Orally Disintegrating Films Using a Factorial Design and Mathematical Modeling for Drug Release.
Lee Y; Thapa P; Jeong SH; Woo MH; Choi DH
Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):166-177. PubMed ID: 27904030
[TBL] [Abstract][Full Text] [Related]
2. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
Speer I; Preis M; Breitkreutz J
Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
[TBL] [Abstract][Full Text] [Related]
3. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
Speer I; Lenhart V; Preis M; Breitkreutz J
Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
[TBL] [Abstract][Full Text] [Related]
4. Formulation and in vitro characterization of novel sildenafil citrate-loaded polyvinyl alcohol-polyethylene glycol graft copolymer-based orally dissolving films.
Xu LL; Shi LL; Cao QR; Xu WJ; Cao Y; Zhu XY; Cui JH
Int J Pharm; 2014 Oct; 473(1-2):398-406. PubMed ID: 25079431
[TBL] [Abstract][Full Text] [Related]
5. Development of aprepitant loaded orally disintegrating films for enhanced pharmacokinetic performance.
Sharma R; Kamboj S; Singh G; Rana V
Eur J Pharm Sci; 2016 Mar; 84():55-69. PubMed ID: 26780381
[TBL] [Abstract][Full Text] [Related]
6. Compounding and Characterization of Oral Disintegrating Films Containing Memantine Hydrochloride for Geriatrics.
Rofiq HM; Phang HC; Janakiraman AK; Chew YL; Uddin AH; Sarker ZI; Lee SK; Liew KB
Int J Pharm Compd; 2023; 27(6):512-521. PubMed ID: 38100669
[TBL] [Abstract][Full Text] [Related]
7. Critical material attributes (CMAs) of strip films loaded with poorly water-soluble drug nanoparticles: I. Impact of plasticizer on film properties and dissolution.
Krull SM; Patel HV; Li M; Bilgili E; Davé RN
Eur J Pharm Sci; 2016 Sep; 92():146-55. PubMed ID: 27402100
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate.
Ruslan MFH; Janakiraman AK; Ming LC; Uddin AH; Sarker ZI; Bin LK
Int J Pharm Compd; 2022; 26(2):155-162. PubMed ID: 35413014
[TBL] [Abstract][Full Text] [Related]
10. Combined Atomistic Molecular Calculations and Experimental Investigations for the Architecture, Screening, Optimization, and Characterization of Pyrazinamide Containing Oral Film Formulations for Tuberculosis Management.
Adeleke OA; Monama NO; Tsai PC; Sithole HM; Michniak-Kohn BB
Mol Pharm; 2016 Feb; 13(2):456-71. PubMed ID: 26650101
[TBL] [Abstract][Full Text] [Related]
11. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
12. Application of freeze-drying technology in manufacturing orally disintegrating films.
Liew KB; Odeniyi MA; Peh KK
Pharm Dev Technol; 2016; 21(3):346-53. PubMed ID: 25597618
[TBL] [Abstract][Full Text] [Related]
13. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
Steiner D; Finke JH; Kwade A
Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
[TBL] [Abstract][Full Text] [Related]
14. Formulation of Saxagliptin Oral Films: Optimization, Physicochemical Characterization, In-Vivo Assessment, and In-Vitro Real-Time Release Monitoring via a Novel Polyaniline Nanoparticles-Based Solid-Contact Screen Printed Ion-Selective Electrode.
Makram TS; Eid SM; Abu-Dahab M; AbouGhaly MHH; Elnahas OS
AAPS PharmSciTech; 2024 May; 25(5):116. PubMed ID: 38769223
[TBL] [Abstract][Full Text] [Related]
15. Development and Characterization of an Orodispersible Film for Vitamin D3 Supplementation.
Cupone IE; Dellera E; Marra F; Giori AM
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322282
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vitro evaluation of a polyvinyl alcohol/sodium alginate based orodispersible film containing sildenafil citrate.
Shi LL; Xu WJ; Cao QR; Yang M; Cui JH
Pharmazie; 2014 May; 69(5):327-34. PubMed ID: 24855822
[TBL] [Abstract][Full Text] [Related]
17. Development and optimization of press coated tablets of release engineered valsartan for pulsatile delivery.
Shah S; Patel R; Soniwala M; Chavda J
Drug Dev Ind Pharm; 2015; 41(11):1835-46. PubMed ID: 25721985
[TBL] [Abstract][Full Text] [Related]
18. Characterization and optimization of orodispersible mosapride film formulations.
ElMeshad AN; El Hagrasy AS
AAPS PharmSciTech; 2011 Dec; 12(4):1384-92. PubMed ID: 22009305
[TBL] [Abstract][Full Text] [Related]
19. Formulation, Characterization, and Optimization of Captopril Fast-Dissolving Oral Films.
Rezaee F; Ganji F
AAPS PharmSciTech; 2018 Jul; 19(5):2203-2212. PubMed ID: 29728997
[TBL] [Abstract][Full Text] [Related]
20. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films.
Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ
Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]